Minerva Neurosciences (NERV) Expected to Announce Quarterly Earnings on Thursday

Minerva Neurosciences (NASDAQ:NERVGet Free Report) is anticipated to issue its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($1.05) per share for the quarter.

Minerva Neurosciences Trading Down 5.1 %

NASDAQ:NERV opened at $1.85 on Thursday. The firm has a market capitalization of $12.93 million, a price-to-earnings ratio of -4.20 and a beta of 0.12. The firm’s fifty day simple moving average is $2.20 and its 200 day simple moving average is $2.43. Minerva Neurosciences has a twelve month low of $1.80 and a twelve month high of $9.40.

Analysts Set New Price Targets

Several equities analysts recently weighed in on NERV shares. StockNews.com started coverage on shares of Minerva Neurosciences in a report on Friday, February 14th. They set a “sell” rating on the stock. HC Wainwright restated a “neutral” rating and set a $5.00 target price on shares of Minerva Neurosciences in a report on Wednesday, November 6th.

Check Out Our Latest Research Report on NERV

Minerva Neurosciences Company Profile

(Get Free Report)

Minerva Neurosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders.

See Also

Earnings History for Minerva Neurosciences (NASDAQ:NERV)

Receive News & Ratings for Minerva Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Minerva Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.